RecruitingNCT05426928

Thermodynamic Model of Hyperthermia in Humans Undergoing HIPEC

Development of a Computational, Thermodynamic Model of Intraabdominal Hyperthermia in Humans Undergoing HIPEC


Sponsor

Henry Ford Health System

Enrollment

30 participants

Start Date

Sep 22, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a well-established alternative for patients with peritoneal surface malignancies. Although HIPEC has a predetermined protocol to manage body temperature, the resultant bladder and core-body temperatures are highly variable and unstable in clinical practice. Such results highlight an incomplete understanding of the thermodynamic processes during HIPEC in humans. Previous clinical and animal investigations have studied abdominal hyperthermia, but a full human model incorporating patient variables, heat delivery, and the impact of the circulatory system and anesthesia in HIPEC has not been established. This project seeks to develop and validate a computational thermodynamic model using prospective real-world data from humans undergoing HIPEC surgery. It is hypothesized that by incorporating patient, anesthetic, and perfusion-related variables in a thermodynamic model, the temperatures inside and outside the abdomen during HIPEC can be predicted.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Adults (at least 18 years or older)
  • Scheduled to undergo HIPEC surgery for abdominal cancer at HFH-Main

Exclusion Criteria3

  • Pregnant females
  • Minors
  • Disease not amenable for treatment with HIPEC after surgical examination.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERAdditional temperature monitoring/recording

All patients in this study will receive the same standard of care treatment for their HIPEC procedure. The only difference will be the use of additional temperature probes to collect more robust data regarding intraabdominal temperature, and the prospective collection of actual boundary conditions of the system.


Locations(1)

Katherine Nowak

Detroit, Michigan, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05426928


Related Trials